ABCL
SetupConviction 82LongHealthcareScan · Thu, Sep 24, 2026AbCellera Biologics Inc. (ABCL) closed at $12.65 (+2.76%) on Sep 24, 2026. It is in the "Setting up" lane with a high tight flag pattern. Price is above its 50-day and above its 200-day moving average. RSI(14) 65, RS Rating 99, -0.6% from its 52-week high, +268.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Trade plan
LongReward : Risk1.01Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Breaking out nowAug 25 – Sep 172 scans
- Setting upSep 23 – Sep 242 scans
Recent news
- How Investors Are Reacting To AbCellera Stock As Phase 2 Data Nearssimplywall.st · Thu, Sep 24, 2026
- ABCL Reinstated by Goldman Sachs -- Neutral Rating with Price TaGuruFocus · Thu, Sep 24, 2026
- Goldman Sachs resumes AbCellera stock coverage with neutral rating By Investing.comInvesting.com Canada · Thu, Sep 24, 2026
- ABCL Looks 201.0% Overvalued on GF Value™GuruFocus · Thu, Sep 24, 2026
- ABCL Oct 2026 18.000 call (ABCL261016C00018000) stock price, news, quote and historyuk.finance.yahoo.com · Wed, Sep 23, 2026
- ABCL Stock Surges 121% in 3 Months: Here's What You Need to KnowYahoo Finance · Tue, Sep 22, 2026
Congress activity
Disclosed STOCK Act trades in ABCL
Insider activity
SEC Form 4 transactions in ABCL · open-market 4 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hayden Michael R Director · Common Shares · 2026-08-24 | Buy | 53.61K | $570K | 2026-08-24 | 2026-08-24 |
Montalbano John S. Director · Common Shares · 2026-08-18 | Buy | 10K | $110K | 2026-08-18 | 2026-08-18 |
Booth Andrew Chief Financial Officer · Common Shares · 2026-08-14 | Buy | 37.2K | $384K | 2026-08-14 | 2026-08-14 |
Hayden Michael R Director · Common Shares · 2026-08-12 | Buy | 46.39K | $481K | 2026-08-12 | 2026-08-14 |
Hayden Michael R Director · Common Shares · 2026-08-11 | Gift | 50K | — | 2026-08-11 | 2026-08-13 |
Sandor Victor Director · Share option (right to buy) · 2026-07-01 | Grant | 152.21K | — | 2026-07-01 | 2026-07-06 |
Seely Lynn Director · Share option (right to buy) · 2026-07-01 | Grant | 152.21K | — | 2026-07-01 | 2026-07-06 |
Hayden Michael R Director · Share option (right to buy) · 2026-06-11 | Grant | 111.7K | — | 2026-06-11 | 2026-06-12 |
Quake Stephen Director · Share option (right to buy) · 2026-06-11 | Grant | 111.7K | — | 2026-06-11 | 2026-06-12 |
Montalbano John S. Director · Share option (right to buy) · 2026-06-11 | Grant | 111.7K | — | 2026-06-11 | 2026-06-12 |
SEC filings
EDGAR filings in ABCL · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.